REQUEST FOR MEDICAL EXEMPTION
FROM MANDATORY IMMUNIZATION
SCHOOL FORM
PAGE 4 OF 4MAY 2021
Table 2. Examples of Conditions incorrectly perceived as contraindications or precautions
to vaccination* (i.e., vaccines may be given under these conditions)
Vaccine
Conditions incorrectly perceived as contraindications and precautions to vaccines
(i.e., vaccines may be given under these conditions)
General for MMR, Hib,
HepB, Varicella, PCV13,
MenACWY
• History of Guillain-Barré syndrome
• Recent exposure to an infectious disease
• History of penicillin allergy, other nonvaccine allergies, relatives with allergies, or
receiving allergen extract immunotherapy
DTaP • Fever within 48 hours after vaccination with a previous dose of DTP or DTaP
• Collapse or shock like state (i.e., hypotonic hyporesponsive episode) within 48 hours
after receiving a previous dose of DTP/DTaP
• Seizure ≤ 3 days after receiving a previous dose of DTP/DTaP
• Persistent, inconsolable crying lasting ≥ 3 hours within 48 hours after receiving a
previous dose of DTP/DTaP
• Family history of seizures
• Family history of sudden infant death syndrome
• Family history of an adverse event after DTP/DTaP
• Stable neurologic conditions (e.g., cerebral palsy, well-controlled seizures, or
developmental delay)
Hepatitis B (HepB) • Pregnancy
• Autoimmune disease (e.g., systemic lupus erythematosus or rheumatoid arthritis)
Inuenza, inactivated
injectable (IIV)
• Nonsevere (e.g., contact) allergy to latex, thimerosal, or egg
MMR • Breastfeeding
• Pregnancy of recipient’s mother or other close or household contact
• Recipient is female of child-bearing age
• Immunodecient family member or household contact
• Asymptomatic or mildly symptomatic HIV infection
• Allergy to eggs
Tdap • History of fever of ≥ 40.5° C (≥ 105° F) for < 48 hours after vaccination with previous
dose of DTP/DTaP
• History of collapse or shock-like state (hypotonic hyporesponsive episode) within 48
hours after receiving a previous dose of DTP/DTaP
• History of persistent, inconsolable crying lasting > 3 hours within 48 hours of receiving a
previous dose of DTP/DTaP
• History of extensive limb swelling after DTP/DTaP/Td that is not an Arthus-type reaction
• History of stable neurologic disorder
• Immunosuppression
Varicella • Pregnancy of recipient’s mother or other close or household contact
• Immunodecient family member or household contact
• Asymptomatic or mildly symptomatic HIV infection
• Humoral immunodeciency (e.g., agammaglobulinemia)
* For a complete list of conditions, please review the ACIP Guide to Contraindications and Precautions accessible at https://www.cdc.gov/vaccines/hcp/
acip-recs/general-recs/contraindications.html.